Form D · Pharmaceuticals
Stream Biomedical, Inc.
Houston, TX · CIK 0001900573
Offering snapshot reported Jan 10, 2022 · SEC filing
- Reported sold
- $21.5M Offering amount: $21.5M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Dec 13, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 10, 2022 | Initial | $21,500,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-428508
Source: Form D, filed Jan 10, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Fred Callori | Director |
| Amanda De La Garza | Director |
| Chris Garabedian | Director |
| William Schwieterman | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2450 Holcombe Boulevard Suite J
Houston, TX, 77021
Houston, TX, 77021